Skip to main content
. Author manuscript; available in PMC: 2023 Mar 1.
Published in final edited form as: Ophthalmol Glaucoma. 2021 Aug 18;5(2):128–136. doi: 10.1016/j.ogla.2021.08.003

Table 2:

Type of autoimmune diseases present in primary open angle glaucoma and control patients undergoing ophthalmic surgery

Predominant Immune Mechanism POAG % (n = 172) Controls % (n = 179) p-value
T-cell mediated 11.6 5.0 0.02
 • Psoriasis 4.1 2.8
 • Non-infectious anterior uveitis 2.9 0.6
 • Alopecia areata 1.2 0
 • Giant cell arteritis 0.6 0
 • Polymyalgia rheumatica 1.2 0.6
 • Multiple sclerosis 0.6 0
 • Psoriatic arthritis 0.6 1.1
 • Ankylosing spondylitis 0.6 0
B-cell mediated 2.9 2.8 >0.99
 • Graves’ disease 1.7 0
 • Raynaud’s syndrome 1.2 1.7
 • Systemic lupus erythematosus 0 0.6
 • Meniere’s disease 0 0.6
Combined T-cell and B-cell mediated 9.9 7.3 0.38
 • Rheumatoid arthritis 4.6 2.8
 • Juvenile rheumatoid arthritis 1.2 0
 • Inflammatory polyarthropathy (ANA+) 0.6 0
 • Immune thrombocytopenic purpura 0.6 0
 • Hashimoto’s thyroiditis 0.6 1.7
 • Autoimmune hepatitis 0.6 0
 • Rheumatic fever 0.6 0
 • Inflammatory bowel disease 0.6 1.1
 • Sjogren syndrome 0.6 1.7

Significant p-values are in bold.

Note: % Autoimmune diseases add up to higher % than the overall prevalence as some patients had multiple autoimmune diseases.

Abbreviation: ANA, anti-nuclear antibody; POAG, primary open angle glaucoma.